Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Urology Reports
Published in: Current Urology Reports 5/2015

01-05-2015 | Urothelial Cancer (A Sagalowsky, Section Editor)

Perioperative Strategies to Reduce Postoperative Complications After Radical Cystectomy

Authors: Jeffrey J. Tomaszewski, Marc C. Smaldone

Published in: Current Urology Reports | Issue 5/2015

Login to get access

Abstract

Radical cystectomy with creation of urinary diversion is the standard treatment for muscle-invasive urothelial carcinoma of the bladder. Despite advances in perioperative care, radical cystectomy is associated with significant morbidity. Reduction in perioperative morbidity and mortality remains a primary focus of bladder cancer outcome improvement. A number of evidence-based approaches to perioperative care have been proposed to reduce the overall burden of complications associated with radical cystectomy. Herein, we highlight and review recent and evolving evidence-based strategies to minimize the morbidity associated with surgical management of muscle-invasive bladder cancer.
Literature
1.
Clark PE, Agarwal N, Biagioli MC, et al. Bladder cancer. J Natl Compr Canc Netw. 2013;11:446.PubMed
2.
Meyer JP, Blick C, Arumainayagam N, et al. A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients. BJU Int. 2009;103:680.CrossRefPubMed
3.
Cookson MS, Chang SS, Wells N, et al. Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. J Urol. 2003;169:101.CrossRefPubMed
4.•
Mitra AP, Quinn DI, Dorff TB, et al. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012;109:846. A powerful nomogram to predict survival following radical cystectomy.CrossRefPubMed
5.
Sonpavde G, Khan MM, Lerner SP, et al. Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol. 2011;185:456.CrossRefPubMed
6.
Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164.CrossRefPubMed
7.
Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666.PubMed
8.
Chang SS, Baumgartner RG, Wells N, et al. Causes of increased hospital stay after radical cystectomy in a clinical pathway setting. J Urol. 2002;167:208.CrossRefPubMed
9.
Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007;178:2314.CrossRefPubMed
10.
Pruthi RS, Nielsen M, Smith A, et al. Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. J Am Coll Surg. 2010;210:93.CrossRefPubMed
11.
Lawrentschuk N, Colombo R, Hakenberg OW, et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol. 2010;57:983.CrossRefPubMed
12.
Morgan TM, Keegan KA, Barocas DA, et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011;186:829.CrossRefPubMed
13.••
Korc-Grodzicki B, Downey RJ, Shahrokni A, et al. Surgical considerations in older adults with cancer. J Clin Oncol. 2014;32:2647. Article nicely highlights the numerous challenges associated with surgery among the elderly and comorbid. Contains numerous suggestions on improving outcomes in said population.CrossRefPubMed
14.
Revenig LM, Canter DJ, Taylor MD, et al. Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg. 2013;217:665.CrossRefPubMed
15.
Large MC, Reichard C, Williams JT, et al. Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy. Urology. 2013;81:123.CrossRefPubMed
16.••
Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217:833. All surgeons should be familiar with and utilize this objective surgical risk calculator. It is useful for pre-operative counseling, appropriate patient selection, and accurately understanding competing risks to morbidity and mortality.CrossRefPubMedCentralPubMed
17.
JJ Tomaszewski, EHA Kutikov, R Mehrazin, B Cung, SP Kim, R Viterbo, D Chen, R Greenberg, H Pitt, NF Esnaola, RG Uzzo, MC Smaldone: Evaluation of the ACS NSQIP surgical risk calculator in patients undergoing radical cystectomy. In: American Urological Association Orlando, FL, 2014.
18.
Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.CrossRefPubMedCentralPubMed
19.
Gregg JR, Cookson MS, Phillips S, et al. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol. 2011;185:90.CrossRefPubMedCentralPubMed
20.•
Lambert JW, Ingham M, Gibbs BB, et al. Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer. Urology. 2013;81:587. Illustrates the important role of serum albumin in pre-operative risk stratification.CrossRefPubMed
21.
22.
Burden S, Todd C, Hill J, et al. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev. 2012;11:CD008879.PubMed
23.
Richards KA, Steinberg GD. Perioperative outcomes in radical cystectomy: how to reduce morbidity? Curr Opin Urol. 2013;23:456.CrossRefPubMed
24.•
Roth B, Birkhauser FD, Zehnder P et al.: Parenteral nutrition does not improve postoperative recovery from radical cystectomy: Results of a Prospective Randomised Trial. Eur Urol, 2012. An important randomized trial of parenteral versus enteral nutrition following radical cystectomy.
25.
Ochoa JB, Makarenkova V, Bansal V. A rational use of immune enhancing diets: when should we use dietary arginine supplementation? Nutr Clin Pract. 2004;19:216.CrossRefPubMed
26.
Drover JW, Dhaliwal R, Weitzel L, et al. Perioperative use of arginine-supplemented diets: a systematic review of the evidence. J Am Coll Surg. 2011;212:385.CrossRefPubMed
27.
Large MC, Kiriluk KJ, DeCastro GJ, et al. The impact of mechanical bowel preparation on postoperative complications for patients undergoing cystectomy and urinary diversion. J Urol. 2012;188:1801.CrossRefPubMed
28.
Hashad MM, Atta M, Elabbady A, et al. Safety of no bowel preparation before ileal urinary diversion. BJU Int. 2012;110:E1109.CrossRefPubMed
29.
Tabibi A, Simforoosh N, Basiri A, et al. Bowel preparation versus no preparation before ileal urinary diversion. Urology. 2007;70:654.CrossRefPubMed
30.
Lavu H, Sell NM, Carter TI, et al. The HYSLAR trial: a prospective randomized controlled trial of the use of a restrictive fluid regimen with 3 % hypertonic saline versus lactated ringers in patients undergoing pancreaticoduodenectomy. Ann Surg. 2014;260:445.CrossRefPubMed
31.
Jarnagin WR, Gonen M, Maithel SK, et al. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg. 2008;248:360.PubMed
32.••
Cerantola Y, Valerio M, Persson B, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS((R))) society recommendations. Clin Nutr. 2013;32:879. Contains the recently proposed guidelines for implementation of a RC specific ERAS clinical pathway. All urologists routinely performing RC should familiarize themselves with the proposed measures.CrossRefPubMed
33.
Pillai P, McEleavy I, Gaughan M, et al. A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy. J Urol. 2011;186:2201.CrossRefPubMed
34.
Lassen K, Soop M, Nygren J, et al. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg. 2009;144:961.CrossRefPubMed
35.
Wuethrich PY, Studer UE, Thalmann GN, et al. Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: results of a prospective randomised trial. Eur Urol. 2014;66:352.CrossRefPubMed
36.••
Nicholson A, Lowe MC, Parker J, et al. Systematic review and meta-analysis of enhanced recovery programmes in surgical patients. Br J Surg. 2014;101:172. Meta-analysis of ERAS programs.CrossRefPubMed
37.•
Dutton TJ, Daugherty MO, Mason RG, et al. Implementation of the Exeter enhanced recovery programme for patients undergoing radical cystectomy. BJU Int. 2014;113:719. Practical and timely experience implementing an ERAS pathway following RC.CrossRefPubMed
38.
Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24:466.CrossRefPubMed
39.
40.
Ansari D, Gianotti L, Schroder J, et al. Fast-track surgery: procedure-specific aspects and future direction. Langenbecks Arch Surg. 2013;398:29.CrossRefPubMed
41.
Hautmann RE, Abol-Enein H, Davidsson T, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol. 2013;63:67.CrossRefPubMed
42.
Khan MS, Elhage O, Challacombe B, et al. Long-term outcomes of robot-assisted radical cystectomy for bladder cancer. Eur Urol. 2013;64:219.CrossRefPubMed
43.••
Karl A, Buchner A, Becker A, et al. A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol. 2014;191:335. A radomized trial implenting ERAS for RC patients.CrossRefPubMed
44.
Maffezzini M, Gerbi G, Campodonico F, et al. Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications. Urology. 2007;69:1107.CrossRefPubMed
45.
Lewis SJ, Egger M, Sylvester PA, et al. Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ. 2001;323:773.CrossRefPubMedCentralPubMed
46.
Patel HR, Cerantola Y, Valerio M, et al. Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy? Eur Urol. 2014;65:263.CrossRefPubMed
47.
Hilton WM, Lotan Y, Parekh DJ, et al. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis. BJU Int. 2013;111:1054.CrossRefPubMed
48.
Kauf TL, Svatek RS, Amiel G, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial. J Urol. 2014;191:1721.CrossRefPubMed
49.
Lee CT, Chang SS, Kamat AM, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol. 2014;66:265.CrossRefPubMed
50.
Share DA, Campbell DA, Birkmeyer N, et al. How a regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care. Health Aff (Millwood). 2011;30:636.CrossRef
51.
Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491.CrossRefPubMedCentralPubMed
52.
Cohen ME, Dimick JB, Bilimoria KY, et al. Risk adjustment in the American College of Surgeons National Surgical Quality Improvement Program: a comparison of logistic versus hierarchical modeling. J Am Coll Surg. 2009;209:687.CrossRefPubMed
53.
Shiloach M, Frencher Jr SK, Steeger JE, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2010;210:6.CrossRefPubMed
54.
Ingraham AM, Richards KE, Hall BL, et al. Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg. 2010;44:251.CrossRefPubMed
55.
Miller DC, Murtagh DS, Suh RS, et al. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer. J Urol. 2011;186:844.CrossRefPubMed
Metadata
Title
Perioperative Strategies to Reduce Postoperative Complications After Radical Cystectomy
Authors
Jeffrey J. Tomaszewski
Marc C. Smaldone
Publication date
01-05-2015
Publisher
Springer US
Published in
Current Urology Reports / Issue 5/2015
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-015-0503-0

Other articles of this Issue 5/2015

Current Urology Reports 5/2015 Go to the issue

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

Lymph Node Staging in Prostate Cancer

Female Urology (K Kobashi, Section Editor)

Management of Apical Pelvic Organ Prolapse

Urothelial Cancer (A Sagalowsky, Section Editor)

Postoperative Changes in Serum CO2 as an Indicator of Postoperative Complications After Radical Cystectomy

Urosurgery (J Collins, Section Editor)

Organ-Confined Prostate Cancer: Are We Moving Towards More or Less Radical Surgical Intervention?

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

Percutaneous Stone Removal: New Approaches to Access and Imaging

New Imaging Techniques (A Rastinehad and S Rais-Bahrami, Section Editors)

Role of Sodium Fluoride PET Imaging for Identification of Bony Metastases in Prostate Cancer Patients